The management of superficial bladder cancer.
Oosterlinck
W
W
Department of Urology, University Hospital, Gent, Belgium. willem.oosterlinck@rug.ac.nl
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000283:Administration, Intravesical; D001500:BCG Vaccine / Q000627:therapeutic use; D001706:Biopsy / Q000379:methods; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D009364:Neoplasm Recurrence, Local; D015588:Observer Variation; D011379:Prognosis; D001749:Urinary Bladder Neoplasms / Q000175:diagnosis / Q000628:therapy*
D000276:Adjuvants, Immunologic; D001500:BCG Vaccine